Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State Analysis

Office-based cosmetic procedures are increasingly delegated by physicians to nonphysicians across a range of practice settings. These procedures vary substantially in technical complexity and complication risk.

To determine whether state-level scope-of-practice, delegation, and supervision standards for office-based cosmetic procedures scale with procedural risk.

Statutes, administrative codes, and medical, nursing, and cosmetology board guidance were reviewed for all 50 US states and the District of Columbia. Five office-based cosmetic procedures were categorized by risk based on published complication profiles: chemical peels, laser hair removal, neuromodulator injections, dermal filler injections, and ablative laser skin resurfacing. Jurisdictions were classified as aligned, delegated, fragmented, or inverted based on risk-oversight correspondence.

Neuromodulator injections, dermal filler injections, and ablative laser resurfacing were uniformly classified as the practice of medicine. Delegation and supervision standards for higher-risk procedures were frequently comparable with those for lower-risk procedures. Delegated and fragmented archetypes predominated and consistently, risk-stratified oversight was uncommon. In multiple jurisdictions, absent procedure-specific regulatory language effectively permitted broad delegation in practice.

State regulation of office-based cosmetic procedures often fails to align delegation and supervision standards with procedural risk, with implications for clinical practice and patient safety.